JPMorgan Chase & Co’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $170K | Sell |
|
|||||
|
2025
Q2 | $112K | Buy |
|
|||||
|
2025
Q1 | $111K | Sell |
|
|||||
|
2024
Q4 | $167K | Buy |
|
|||||
|
2024
Q3 | $98.3K | Buy |
|
|||||
|
2024
Q2 | $50.2K | Buy |
|
|||||
|
2024
Q1 | $90.4K | Sell |
|
|||||
|
2023
Q4 | $125K | Sell |
|
|||||
|
2023
Q3 | $141K | Buy |
|
|||||
|
2023
Q2 | $174K | Buy |
|
|||||
|
2023
Q1 | $190K | Buy |
|
|||||
|
2022
Q4 | $140K | Sell |
|
|||||
|
2022
Q3 | $156K | Buy |
|
|||||
|
2022
Q2 | $171K | Sell |
|
|||||
|
2022
Q1 | $316K | Buy |
|
|||||
|
2021
Q4 | $239K | Buy |
|
|||||
|
2021
Q3 | $99K | Buy |
|